Skip to main content

Amphotericin b cholesteryl sulfate Pregnancy and Breastfeeding Warnings

Brand names: Amphotec

Amphotericin b cholesteryl sulfate Pregnancy Warnings

Amphotericin B cholesteryl sulfate has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Amphotericin B cholesteryl sulfate should be given during pregnancy only when benefit outweighs risk.

See references

Amphotericin b cholesteryl sulfate Breastfeeding Warnings

There are no data on the excretion of amphotericin B cholesteryl sulfate into human milk. Due to the potential for serious adverse effects in a nursing infant, a decision should be made to discontinue nursing or discontinue the drug, taking into consideration the importance of the drug to the woman.

See references

Does Amphotericin b cholesteryl sulfate interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

See also

References for pregnancy information

  1. (2022) "Product Information. Amphotec (amphotericin B cholesteryl sulfate)." Sequus Pharmaceuticals Inc
  2. "Product Information. Ambisome (amphotericin B liposomal)" Nexstar Pharmaceuticals, San Dimas, CA.

References for breastfeeding information

  1. (2022) "Product Information. Amphotec (amphotericin B cholesteryl sulfate)." Sequus Pharmaceuticals Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer